497 related articles for article (PubMed ID: 37900996)
1. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
Zheng BH; Ni XJ; Liu HB
World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
[TBL] [Abstract][Full Text] [Related]
3. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
4. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
5. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
[TBL] [Abstract][Full Text] [Related]
6. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
Wu MN; Sun JY; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
9. [Exosomal proteomics study in the tumorigenesis, development and treatment of hepatocellular carcinoma].
Zhao L; Xu F; Zhang Y; Xu P
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1992-2000. PubMed ID: 33169565
[TBL] [Abstract][Full Text] [Related]
10. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
12. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
Li C; Xu X
Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
[TBL] [Abstract][Full Text] [Related]
13. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
14. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
Suda T
World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
[TBL] [Abstract][Full Text] [Related]
15. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
[TBL] [Abstract][Full Text] [Related]
16. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
Li S; Yao J; Xie M; Liu Y; Zheng M
J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
[TBL] [Abstract][Full Text] [Related]
18. Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).
Yang S; Wang J; Wang S; Zhou A; Zhao G; Li P
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674180
[TBL] [Abstract][Full Text] [Related]
19. Role of exosomal circular RNAs as microRNA sponges and potential targeting for suppressing hepatocellular carcinoma growth and progression.
Papadopoulos N; Trifylli EM
World J Gastroenterol; 2024 Mar; 30(9):994-998. PubMed ID: 38577187
[TBL] [Abstract][Full Text] [Related]
20. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
